X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Acta Pharmaceutica Sinica B

期刊標題檢索 ACTA PHARM SIN 最新評論: I wanted to ask, did the magazine accept it in the end? How long did i... (2024-05-19)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Acta Pharmaceutica Sinica B]您好,您是該頁面的第 186477 位訪客。

期刊簡介
期刊名稱Acta Pharmaceutica Sinica B Acta Pharmaceutica Sinica B
LetPub Score
8.3
51 ratings
Rate

Reputation
8.9

Influence
7.6

Speed
8.7

期刊簡稱ACTA PHARM SIN B
ISSN2211-3835
E-ISSN2211-3843
h-index28
CiteScore
CiteScoreSJRSNIPCiteScore Rank
22.403.0352.253
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: General Pharmacology, Toxicology and Pharmaceutics
Q11 / 80

自引率 (2023-2024)5.40%自引率趨勢
掲載範囲
Acta Pharmaceutica Sinica B (APSB) is a bimonthly journal, in English, which publishes significant original research articles, rapid communications and high quality reviews of recent advances in all areas of pharmaceutical sciences — including pharmacology, pharmaceutics, medicinal chemistry, natural products, pharmacognosy, pharmaceutical analysis and pharmacokinetics.
官方網站https://www.journals.elsevier.com/acta-pharmaceutica-sinica-b
在線稿件提交https://www.editorialmanager.com/APSB
開放訪問Yes
出版商Elsevier BV
主題領域Pharmacology, Toxicology and Pharmaceutics
出版國/地區Netherlands
發行頻率
創刊年0
每年文章數300每年文章數趨勢
黃金OA百分比98.22%
OA Related Info
APC: No
APC waiver:Check Notes
Other charges: No
Keywords: pharmaceutical science、traditional chinese medicine、pharmaceutics、pharmaceutical chemistry、pharmacokinetics
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PHARMACOLOGY & PHARMACYSCIEQ15/354
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2211-3835%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 19 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Acta Pharmaceutica Sinica B】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Antibiotics-BaselH-index: 0

    CiteScore: 7.30
    Pharmacology Research & PerspectivesH-index: 0

    CiteScore: 5.30
    Therapeutics and Clinical Risk ManagementH-index: 0

    CiteScore: 5.30
    Revista Brasileira de Farmacognosia-Brazilian Journal of PharmacognosyH-index: 37

    CiteScore: 2.60
    Infarma Pharmaceutical SciencesH-index: 0

    CiteScore: 0.10
    Mental Health ClinicianH-index: 0

    CiteScore: 1.90
    Pharmacological Research Modern Chinese MedicineH-index: 0

    CiteScore: 1.60
    學科內最受檢索的期刊 頁面查看次數
    Antibiotics-Basel33410
    Pharmacology Research & Perspectives17082
    Revista Brasileira de Farmacognosia-Brazilian Journal of Pharmacognosy15641
    Therapeutics and Clinical Risk Management5910
    Infarma Pharmaceutical Sciences1521
    Pharmacological Research Modern Chinese Medicine1226
    Mental Health Clinician358
  •  

    Acta Pharmaceutica Sinica B Acta Pharmaceutica Sinica B
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/8)
  [Acta Pharmaceutica Sinica B] 的評論撰寫評論
作者:


領域: 医药科学
審稿時間: 2.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-30 22:34:11 評論於
 (0) 讚! |   

作者: 努力啊大凌春


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-19 22:11:22 評論於
I wanted to ask, did the magazine accept it in the end? How long did it take to accept?
(0) 讚! | 努力啊大凌春

作者: 努力啊大凌春


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-19 10:29:02 評論於
Review speed: 2.0
Research focus: Tumor
Experience sharing: The first review took two months, with minor revisions from two reviewers and a major revision. After giving two months for revisions, the second review also took another two months and is still pending external review. Feeling anxious
(0) 讚! | 努力啊大凌春

作者: 削月以松


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-26 19:06:46 評論於
There are also opinions on general initial rejections
(0) 讚! | 削月以松

作者: 北陆永长


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-21 10:19:01 評論於
Review speed: 1.0
Focus of research: Pulmonary vascular
Experience sharing: 4.4 submitted 4.6 with editor 4.10 rejected
(0) 讚! | 北陆永长

作者: 咏春顺慈


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-15 21:56:53 評論於
23.7.25 Submission; 23.9.15 Major Revision; 23.10.10 Revised Submission; 23.12.20 Acceptance Despite the slow efficiency overall, it was a pleasant submission experience. However, the slow publication after acceptance is a concern, especially for those needing publication for graduation
(0) 讚! | 咏春顺慈

作者: 一只瑶瑾呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-14 16:37:03 評論於
The same state, time is long
(0) 讚! | 一只瑶瑾呀

作者: Lucy Larkin


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-12 10:33:28 評論於
Research focus: Biological experience sharing: Circle journals are usually one of the last choices for big shots with 10+ articles
(0) 讚! | Lucy Larkin

作者: 梓婷来了


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-07 17:13:57 評論於
Not yet invested, looking forward to it
(0) 讚! | 梓婷来了

作者: 穿心竹筱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-24 21:01:35 評論於
It's been 7 days, and you're still in this state. How long will it take for you to recover from this state?
(0) 讚! | 穿心竹筱

作者: Jack Titus


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-24 10:15:15 評論於
How long has it been under review since the first revision?
(0) 讚! | Jack Titus

作者: 震雷超霞


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-23 18:17:03 評論於
Review speed: 2.0 | Submission Hit Rate: 50.0 
Emphasized research direction: Pharmacology
Experience sharing: One revision took less than a month, with one reviewer still having additional questions. Second revision submitted, currently awaiting response
(0) 讚! | 震雷超霞

作者: 光明亦瑶


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-17 11:22:56 評論於
How is it going? Is the review finished? Was it reviewed in just one day?
(0) 讚! | 光明亦瑶

作者: Lucy Larkin


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-16 18:19:33 評論於
This magazine needs connections
(0) 讚! | Lucy Larkin

作者: Miranda Dierser


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-16 13:12:24 評論於
Not selected yet
(0) 讚! | Miranda Dierser

作者: 奉天雨雁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-07 19:06:11 評論於
Submission success rate: 25.0
Experience Sharing: Submitted an article, currently under review after 1 week, hoping for good news
(0) 讚! | 奉天雨雁

作者: AugensternNN


領域: 化学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-05 10:48:00 評論於
Hello, what is the current status? Is the review period long?
(0) 讚! | AugensternNN

作者: 削月以松


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-01-02 15:25:18 評論於
Having few comments doesn't mean having no comments. It may indicate that the reviewer fundamentally denied the article, for example due to a lack of novelty, resulting in a rejection. You just didn't notice it
(0) 讚! | 削月以松

作者: 海大小朱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-21 15:06:03 評論於
Renowned pharmaceutical journal, said to be friendly to Chinese people, has seen a rapid increase in Impact Factor in recent years. Hope it can continue to excel!
(0) 讚! | 海大小朱

作者: 先天乐巧


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-29 21:41:02 評論於
Review speed: 3.0 Experience sharing: It took over a month to submit for review, and then it took almost two months to receive the review comments, a total of ten comments, all of which were minor revisions, but the editor rejected the paper without explaining the reasons! This is very confusing!
(0) 讚! | 先天乐巧

作者: Nicola Robin


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-16 16:26:02 評論於
How did your article turn out in the end?
(0) 讚! | Nicola Robin

作者: Nicola Robin


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-12 09:30:35 評論於
Hello, have your status changed now? I have been with editor for 3 weeks as well
(0) 讚! | Nicola Robin

作者: 黑山立果


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-19 20:27:46 評論於
I have submitted my manuscript for almost a month, and it is still with the editor. I have no idea what these editors are doing
(0) 讚! | 黑山立果

作者: 会心琼华


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-16 16:51:12 評論於
Submitted for 16 days, still with editor. I advise colleagues who are impatient not to try blindly when there is nothing to do. It's killing time!
(0) 讚! | 会心琼华

作者: 3519


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-11 23:22:35 評論於
How long does it take to finish with the editor?
(0) 讚! | 3519

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/8)

開始撰寫 [Acta Pharmaceutica Sinica B] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*